China
· Delayed Price · Currency is CNY Betta Pharmaceuticals Statistics
Total Valuation
SHE:300558 has a market cap or net worth of CNY 20.06 billion. The enterprise value is 22.10 billion.
| Market Cap | 20.06B |
| Enterprise Value | 22.10B |
Important Dates
The next estimated earnings date is Thursday, April 16, 2026.
| Earnings Date | Apr 16, 2026 |
| Ex-Dividend Date | Jun 17, 2025 |
Share Statistics
SHE:300558 has 420.73 million shares outstanding. The number of shares has decreased by -0.15% in one year.
| Current Share Class | 420.73M |
| Shares Outstanding | 420.73M |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | -2.54% |
| Owned by Insiders (%) | 3.35% |
| Owned by Institutions (%) | 13.38% |
| Float | 233.55M |
Valuation Ratios
The trailing PE ratio is 66.17 and the forward PE ratio is 26.07.
| PE Ratio | 66.17 |
| Forward PE | 26.07 |
| PS Ratio | 6.14 |
| PB Ratio | 3.39 |
| P/TBV Ratio | 7.37 |
| P/FCF Ratio | 426.91 |
| P/OCF Ratio | 26.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.34, with an EV/FCF ratio of 470.43.
| EV / Earnings | 72.87 |
| EV / Sales | 6.77 |
| EV / EBITDA | 23.34 |
| EV / EBIT | 42.30 |
| EV / FCF | 470.43 |
Financial Position
The company has a current ratio of 0.77, with a Debt / Equity ratio of 0.42.
| Current Ratio | 0.77 |
| Quick Ratio | 0.44 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.60 |
| Debt / FCF | 52.36 |
| Interest Coverage | 7.31 |
Financial Efficiency
Return on equity (ROE) is 4.89% and return on invested capital (ROIC) is 3.97%.
| Return on Equity (ROE) | 4.89% |
| Return on Assets (ROA) | 3.43% |
| Return on Invested Capital (ROIC) | 3.97% |
| Return on Capital Employed (ROCE) | 6.72% |
| Revenue Per Employee | 1.66M |
| Profits Per Employee | 154,654 |
| Employee Count | 1,961 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, SHE:300558 has paid 69.08 million in taxes.
| Income Tax | 69.08M |
| Effective Tax Rate | 19.52% |
Stock Price Statistics
The stock price has decreased by -14.05% in the last 52 weeks. The beta is 0.65, so SHE:300558's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -14.05% |
| 50-Day Moving Average | 56.60 |
| 200-Day Moving Average | 57.84 |
| Relative Strength Index (RSI) | 27.72 |
| Average Volume (20 Days) | 4,841,649 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300558 had revenue of CNY 3.26 billion and earned 303.28 million in profits. Earnings per share was 0.72.
| Revenue | 3.26B |
| Gross Profit | 2.57B |
| Operating Income | 522.43M |
| Pretax Income | 353.91M |
| Net Income | 303.28M |
| EBITDA | 942.98M |
| EBIT | 522.43M |
| Earnings Per Share (EPS) | 0.72 |
Balance Sheet
The company has 491.93 million in cash and 2.46 billion in debt, giving a net cash position of -1.97 billion or -4.68 per share.
| Cash & Cash Equivalents | 491.93M |
| Total Debt | 2.46B |
| Net Cash | -1.97B |
| Net Cash Per Share | -4.68 |
| Equity (Book Value) | 5.92B |
| Book Value Per Share | 13.89 |
| Working Capital | -442.98M |
Cash Flow
In the last 12 months, operating cash flow was 748.26 million and capital expenditures -701.28 million, giving a free cash flow of 46.98 million.
| Operating Cash Flow | 748.26M |
| Capital Expenditures | -701.28M |
| Free Cash Flow | 46.98M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 78.77%, with operating and profit margins of 16.00% and 9.29%.
| Gross Margin | 78.77% |
| Operating Margin | 16.00% |
| Pretax Margin | 10.84% |
| Profit Margin | 9.29% |
| EBITDA Margin | 28.88% |
| EBIT Margin | 16.00% |
| FCF Margin | 1.44% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.42%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.42% |
| Dividend Growth (YoY) | 17.02% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 60.29% |
| Buyback Yield | 0.15% |
| Shareholder Yield | 0.57% |
| Earnings Yield | 1.51% |
| FCF Yield | 0.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:300558 has an Altman Z-Score of 4.65 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.65 |
| Piotroski F-Score | 6 |